US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 1.090
- -0.010-0.91%
Close Jan 17 16:00 ET
- 1.090
- 0.0000.00%
Post 19:56 ET
227.43MMarket Cap-1.54P/E (TTM)
1.140High1.075Low4.33MVolume1.100Open1.100Pre Close4.75MTurnover2.12%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High5.80P/B222.40MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM5.91%Amplitude0.291Historical Low1.095Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
Sign in to post a comment
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway | 4D Molecular Therapeutics
1
1
$Sangamo Therapeutics (SGMO.US)$ lets go~~~~up
The trading year ended with markets declining
Shortly after close, the $S&P 500 Index (.SPX.US)$ dipped 0.43% to 5,881.63, the $Dow Jones Industrial Average (.DJI.US)$ edged down 0.07% to 42,544.22, and the $Nasdaq Composite Index (.IXIC.US)$ dropped 0.9% to 19,310.79.
For the year, the Nasdaq Composite led the way, rising 29%. The S&P 500 was up 23% (a second straight year of 20% gains) and the Dow added almost 13%.
MACR...
Shortly after close, the $S&P 500 Index (.SPX.US)$ dipped 0.43% to 5,881.63, the $Dow Jones Industrial Average (.DJI.US)$ edged down 0.07% to 42,544.22, and the $Nasdaq Composite Index (.IXIC.US)$ dropped 0.9% to 19,310.79.
For the year, the Nasdaq Composite led the way, rising 29%. The S&P 500 was up 23% (a second straight year of 20% gains) and the Dow added almost 13%.
MACR...
63
6
8
Barclay's keeps overweight and maintains 9 dollar target. Says they assigned limited value to the Hemo A program. Very Intresting
4
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. No buy pressure/momentum- No day t...
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. No buy pressure/momentum- No day t...
74
23
9
$Sangamo Therapeutics (SGMO.US)$ buy buy buy
3
1
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
BigAlMoney : Sangamo's Fabry results are much better. We have Accelerated Approval Pathway from FDA recently. Gets a drug to market 3 years sooner. No expensive Phase 3 required. Existing cohorts just monitored by eGFR, 5 dollar lab test. BLA can be filed thus year. In discussions with several big Pharma for buyout or Partnership.